Bisaramil

Drug Profile

Bisaramil

Alternative Names: RGH 2957; Yutac

Latest Information Update: 08 Nov 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Gedeon Richter
  • Developer Taiho Pharmaceutical
  • Class Benzoic acids; Class Ic antiarrhythmics; Class IV antiarrhythmics; Small molecules
  • Mechanism of Action Calcium channel antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Arrhythmias

Most Recent Events

  • 08 Nov 2006 Discontinued - Phase-II for Arrhythmias in Japan (PO)
  • 09 Nov 1999 A preclinical study has been added to the pharmacodynamics section
  • 08 Aug 1997 Discontinued-II for Arrhythmias in Hungary (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top